Stimulation of MC38 Tumor Growth by Insulin Analog X10 Involves the Serine Synthesis Pathway

Endocrine-Related Cancer (2012) 19 557–574 Stimulation of MC38 tumor growth by insulin analog X10 involves the serine synthesis pathway Henning Hvid1,2, Sarah-Maria Fendt3, Marie-Jose´ Blouin1, Elena Birman1, Gregory Voisin4, Angela Manegold Svendsen5, Russell Frank1, Matthew G Vander Heiden6, Gregory Stephanopoulos3, Bo Falck Hansen2 and Michael Pollak1 1Lady Davis Institute for Medical Research, Jewish General Hospital, 3755 Cote-Ste.-Catherine, Montreal, Quebec, Canada H3T 1E2 2Insulin Biology, Novo Nordisk A/S, DK-2760, Copenhagen, Denmark 3Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA 4Genome Centre Quebec, Montreal, Quebec, Canada H3A 0G1 5Incretin Biology, Novo Nordisk A/S, DK-2760, Copenhagen, Denmark 6Koch Institute for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA (Correspondence should be addressed to H Hvid at Lady Davis Institute for Medical Research, Jewish General Hospital, 3755 Cote-Ste.-Catherine, Montreal, Quebec, Canada H3T 1E2; Email: [email protected]) Abstract Recent evidence suggests that type II diabetes is associated with increased risk and/or aggressive behavior of several cancers, including those arising from the colon. Concerns have been raised that endogenous hyperinsulinemia and/or exogenous insulin and insulin analogs might stimulate proliferation of neoplastic cells. However, the mechanisms underlying possible growth-promoting effects of insulin and insulin analogs in cancer cells in vivo, such as changes in gene expression, are incompletely described. We observed that administration of the insulin analog X10 significantly increased tumor growth and proliferation in a murine colon cancer model (MC38 cell allografts). Insulin and X10 altered gene expression in MC38 tumors in a similar fashion, but X10 was more potent in terms of the number of genes influenced and the magnitude of changes in gene expression. Many of the affected genes were annotated to metabolism, nutrient uptake, and protein synthesis. Strikingly, expression of genes encoding enzymes in the serine synthesis pathway, recently shown to be critical for neoplastic proliferation, was increased following treatment with insulin and X10. Using stable isotopic tracers and mass spectrometry, we confirmed that insulin and X10 increased glucose contribution to serine synthesis in MC38 cells. The data demonstrate that the tumor growth-promoting effects of insulin and X10 are associated with changes in expression of genes involved in cellular energy metabolism and reveal previously unrecognized effects of insulin and X10 on serine synthesis. Endocrine-Related Cancer (2012) 19 557–574 Introduction so-called detection bias (Carstensen et al.2012), Epidemiological studies indicate that obesity and concerns remain that endogenous hyperinsulinemia type II diabetes are associated with an increased risk or therapeutic use of insulin and/or insulin analogs for development of certain types of cancer, including may increase the growth of existing cancers (Smith & breast, colon, and pancreatic cancer (Adami et al. Gale 2009). Effects of insulin on gene expression are 1991, Calle & Kaaks 2004, Coughlin et al. 2004, well described in its classic target tissues (liver, Ogunleye et al. 2009, Chen 2011). While a recent study muscle, and fat), where insulin, for example, increases raised the possibility that the apparent link between expression of genes involved in glycolysis and type II diabetes and cancer may be explained by the lipogenesis and decreases expression of genes involved Endocrine-Related Cancer (2012) 19 557–574 Downloaded from Bioscientifica.comDOI: 10.1530/ERC-12-0125 at 10/02/2021 09:45:14PM 1351–0088/12/019–557 q 2012 Society for Endocrinology Printed in Great Britain Online version via http://www.endocrinology-journals.orgvia free access H Hvid et al.: Insulin X10 and the serine synthesis pathway in gluconeogenesis (O’Brien & Granner 1996, Saltiel Materials and methods & Kahn 2001). However, in nonclassic target tissues, Animal experiments in particular cancer cells, less is known about the effects of insulin on gene expression. Importantly, the Male C57BL/6J mice were purchased from Jackson precise changes in gene expression secondary to Laboratories (Bar Habor, ME, USA). At arrival, the insulin receptor (IR) activation that mediate a possible mice were 18 weeks old and had been maintained on a growth-promoting effect of insulin on cancer cells high-fat diet for 12 weeks (rodent diet with 60 kcal% in vivo are not well described, even though mitogenic fat, Research Diets, Inc., New Brunswick, NJ, USA, potential of insulin and different analogs has been cat. no. D12492). The mice were housed one mouse per examined in several studies in vitro (Milazzo et al. cage, with ad libitum access to drinking water (tap 1997, Kurtzhals et al. 2000, Listov-Saabye et al. water) and high-fat diet. The temperature in the animal 2009, Sommerfeld et al. 2010). room was maintained at 20–25 8C. The light/dark cycle Mitogenic effects of insulin and insulin analogs are was 14/10 h. The animals were acclimatized for often considered separately from metabolic effects, 10 days before the start of the experiment. At with emphasis on the role of cell cycle progression experimental day 1, each mouse was injected subcu- ! 5 and antiapoptotic mechanisms via activation of the taneously in the right flank with 5.0 10 MC38 cells suspended in 0.1 ml PBS. Starting on experimental phosphoinositide 3-kinase/Akt pathway and the day 1, each mouse was injected with either vehicle RAS/RAF/MAPK pathway (Lawlor & Alessi 2001, (containing 5 mM phosphate, 140 mM NaCl, and Jensen & De Meyts 2009, Sciacca et al. 2010). For 70 ppm polysorbate 20), recombinant native human example, IR agonists that bind the IR and induce insulin (Novo Nordisk A/S, Copenhagen, Denmark) metabolic effects such as glycogen synthesis but only 100 IU/kg (600 nmol/kg), or insulin analog X10 weak mitogenic effects have been described (Jensen (B10Asp; Novo Nordisk A/S) 100 IU/kg (600 nmol/kg). et al. 2007). However, a growing body of evidence Injections were thereafter administered twice daily, indicates that the model of independent metabolic at w0800 and 1800 h. The animals were weighed and mitogenic consequences of IR activation may be at the start of the experiment and twice weekly too simple, as increased proliferation requires thereafter, and doses of insulin and X10 were alterations in cellular metabolism (Vander Heiden adjusted continuously according to bodyweight. The et al. 2009, Locasale et al. 2011, Possemato et al. tumor size was measured three times per week and 2011). Thus, while for some tissues insulin may have the tumor volume was calculated using the following minimal proliferation-stimulating effects, in those formula: length!width2!0.52. On experimental day cases where insulin does favor proliferation, this is 17, the mice were treated once and killed 6 h after the hypothesized to require a coordinated modification of last injection. After the animals were killed, samples metabolic processes, in order to ensure that both the of tumor allografts and colon were collected and energetic needs and the biosynthetic needs for cell immediately preserved in RNAlater (Qiagen, Inc.), division are met. 10% neutral buffered formalin, or snap-frozen in Previous in vivo studies revealed the rapid-acting liquid nitrogen for subsequent analysis. In a parallel insulin analog X10, which has increased affinity for the study, animals were killed at 15 min (two animals per IR and the insulin-like growth factor 1 receptor treatment), 1 h (three animals per treatment), or 6 h (IGF1R) and displays decreased off-rate from the IR (two animals per treatment) after the last treatment (Hansen et al. 1996, Slieker et al. 1997, Kurtzhals et al. with vehicle, insulin, or X10. After the animals were 2000), increased the tumor incidence in female rats killed, tissue samples were collected and preserved by compared with native human insulin (Dideriksen et al. snap freezing in liquid nitrogen. 1992). We therefore examined the effects of chronic treatment with insulin and the insulin analog X10 on global gene expression in colon cancer allografts. Cell culture In order to model the clinical treatment of type II MC38 cells (gift from Dr Pnina Brodt, McGill diabetes, we used MC38 cell allografts in mice with University, Montreal, QC, Canada) were plated in diet-induced obesity and hyperinsulinemia (Mashhedi six-well plates and cultivated for 2 days in growth et al. 2011). After treatment with insulin or X10 for medium (DMEM medium containing 4.5 g/l glucose 17 days, gene expression in the tumor allografts was (Wisent, Inc., Montreal, QC, Canada, cat. no. 319- studied using microarray technology and quantitative 005)), supplemented with 10 vol% fetal bovine serum real-time PCR (qRT-PCR). (FBS; Invitrogen), and 20 mg/ml gentamicin (Sandoz Downloaded from Bioscientifica.com at 10/02/2021 09:45:14PM via free access 558 www.endocrinology-journals.org Endocrine-Related Cancer (2012) 19 557–574 Canada, Boucherville, QC, Canada). At day 2, the cells cells were counted. The area of the secondary counting were 60–70% confluent and growth medium was frame was 6% of the area of the primary counting removed, and the cells were rinsed once in PBS before frame, so it was possible to obtain an approximate starvation medium was added (DMEM medium equal and sufficient number of counts as recommended containing 4.5 g/l glucose but no phenol red and only previously (Gundersen et al. 1988). The counts were 0.25 vol% FBS). Cells were starved overnight adjusted for the different sizes of the counting frames, (experiment 1) or for 3 h (experiments 2 and 3). We and the percentage of positively stained cells was observed no difference between overnight and 3-h calculated. starvation. After the starvation period, cells were In the colon, the number of positively stained cells treated with native human insulin or insulin X10 at was quantified per crypt. In each section, the total final concentrations of 1, 10, or 100 nM (100 nM only number of cells and the number of positive cells were used in experiment 1).

Load more